Will 2016 bring full transparency for drug company payments to doctors in the UK?

Will the ABPI central database go far enough?

Pharmaceutical firms currently pay about £40m every year to healthcare professionals, including doctors and pharmacists. These payments could be for anything from expert advice to sponsoring a healthcare professional’s medical education. Now, the Association of the British Pharmaceutical Industry (ABPI) has created a central database, going live in June, on which its member companies, and others that have signed up to comply with the ABPI code of practice, will disclose who these payments are made to, and for what. At the same time, Jeremy Hunt’s “sunshine rule” will make it mandatory for NHS staff to declare gifts received from drug companies.

Read: How much should patients know about pharma payments to doctors?, the guardian, 18 May 2016.

How will this new transparency affect the complex matrix of relationships between health professionals, pharmaceutical firms, the NHS and, most importantly, patients?

2 thoughts on “Will 2016 bring full transparency for drug company payments to doctors in the UK?”

  1. This is fantastic news and will have a huge effect on providing safeguards for the patients. For too long the big companies have had huge influence with Health professionals and Health Authorities. Financial incentives do not belong in Health Care. You really are doing such a fantastic job of keeping people informed about change, issues and improvements in the Health Industry. A huge well done. Marie Lyon/Chair Association for children damaged by Hormone Pregnancy Tests

    1. Thank you very much for your kind comments Marie.
      I agree this is a move going in the right direction but let’s see what happens…

Have your say! Share your views